en
lv
ru
Investors
Corporate Governance
Financial Calendar
Financial News
Presentations
Documents
Analysts
Shareholders’ Meetings
Investor contacts
Media
Latest News
Photo Library
Media Contacts
Sponsorship and support
Careers
Personnel Policy
Vacancies
Application Form
Internship
Career Contacts
Contacts
Training courses and actual information
Search
Home
Company
About Olainfarm
Business Strategy
Governance and Management
Board
Structure
Supervisory Council
Senior Executive Team
Auditing Committee
Olainfarm Worldwide
Responsibility
Licences and Certificates
Quality Policy
Environment Protection Policy
Participation in Projects
Ongoing projects
Completed projects
Procurements
Awards
History
Articles of Association
In memoriam
Products and Services
Products
Over the Counter (OTC)
Prescription Medicines
Food Supplements
APIs and Intermediates
APIs
Intermediates
Pharmacovigilance
Services
QC/QA Services
Regulatory Services
APIs and Intermediates Development
Final Dosage Forms Development
Contract Manufacturing
Research and Development
R&D of APIs and Intermediates
R&D of Final Dosage Forms
Preclinical Trials
Clinical Trials
Cooperation
Investors
MAJOR SHAREHOLDERS
Shareholding 31 December 2019
Investors
07.25.2015
Investors
Documents
Information on Shares
Dividends
Analysts
Corporate Governance
Financial Calendar
Financial News
Investor Contacts
Presentations
Shareholders’ Meetings
Search
Recent Posts
The new five-year strategy of JSC Olainfarm – sustainable healthcare products and market expansion
September 2, 2020
Mārtiņš Pūriņš leaves his position as JSC Olainfarm Management Board member
July 21, 2020
JSC Olainfarm elects new Chairperson of the Management Board of Tonus Elast Ltd and Latvijas Aptieka Ltd
July 21, 2020
Zane Kotāne has been elected as a member of the Management Board of JSC Olainfarm
July 2, 2020
Lauris Macijevskis leaves his position as JSC Olainfarm Management Board member
June 9, 2020
